THE ZTA TRANSACTIVATOR INVOLVED IN INDUCTION OF LYTIC CYCLE GENE-EXPRESSION IN EPSTEIN-BARR VIRUS-INFECTED LYMPHOCYTES BINDS TO BOTH AP-1 AND ZRE SITES IN TARGET PROMOTER AND ENHANCER REGIONS
THE ZTA TRANSACTIVATOR INVOLVED IN INDUCTION OF LYTIC CYCLE GENE-EXPRESSION IN EPSTEIN-BARR VIRUS-INFECTED LYMPHOCYTES BINDS TO BOTH AP-1 AND ZRE SITES IN TARGET PROMOTER AND ENHANCER REGIONS
复制标题
DOI:
10.1128/jvi.64.3.1143-1155.1990
复制
发表时间:
1990-03-01
影响因子:
5.4
通讯作者:
HAYWARD, SD
中科院分区:
文献类型:
--
作者:
LIEBERMAN, PM;HARDWICK, JM;HAYWARD, SD
The BZLF1 or zta immediate-early gene of Epstein-Barr virus (EBV) encodes a 33-kilodalton phosphorylated nuclear protein that is a specific transcriptional activator of the EBV lytic cycle when introduced into latently infected B lymphocytes. We have shown previously that the divergent EBV DSL target promoter contains two zta-response regions, one within the minimal promoter and the other in an upstream lymphocyte-dependent enhancer region. In this study, we used footprinting and gel mobility retardation assays to reveal that bacterially synthesized Zta fusion proteins bound directly to six TGTGCAA-like motifs within DSL. Four of the Zta-binding sites lay adjacent to cellular TATA and CAAT factor-binding sites within the minimal promoter, and two mapped within the enhancer region. Single-copy oligonucleotides containing these Zta-binding sites conferred Zta responsiveness to heterologous promoters. In addition, the Zta protein, which possesses a similar basic domain to the conserved DNA-binding region of the c-Fos, c-Jun, GCN4, and CREB protein family, proved to bind directly to the consensus AP-1 site in the collagenase 12-O-tetradecanoylphorbol-13-acetate response element. Cotransfected with zta also trans activated a target reporter gene contained inserted wild-type 12-O-tetradecanoylphorbol-13-acetate response element oligonucleotides. Cellular AP-1 binding activity proved to be low in latently EBV-infected Raji cells but was induced (together with Zta protein) after activation of the lytic cycle with 12-O-tetradecanoylphorbol-13-acetate. We conclude that EBV may have captured and modified a cellular gene encoding a c-jun-like DNA-binding protein during its evolutionary divergency from other herpesviruses and that this protein is used to specifically redirect transcriptional activity toward expression of EBV lytic-cycle genes in infected cells.